- Home
- BCRX vs SA Comparison
BCRX vs SA Comparison
Compare BCRX & SA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCRX | SA |
|---|---|---|
| Founded | 1986 | 1979 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.8B |
| IPO Year | 1995 | 2004 |
Fundamental Metrics
Financial Performance| Metric | BCRX | SA |
|---|---|---|
| Price | $9.01 | $27.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | $20.82 | ★ $65.00 |
| AVG Volume (30 Days) | ★ 3.9M | 755.8K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 381.40 | N/A |
| EPS | ★ 1.21 | N/A |
| Revenue | ★ $25,186,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.55 | N/A |
| P/E Ratio | $7.34 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.00 | $11.12 |
| 52 Week High | $11.31 | $40.06 |
Technical Indicators
Market Signals| Indicator | BCRX | SA |
|---|---|---|
| Relative Strength Index (RSI) | 48.21 | 38.77 |
| Support Level | $8.73 | $21.84 |
| Resistance Level | $9.14 | $31.91 |
| Average True Range (ATR) | 0.36 | 1.31 |
| MACD | -0.10 | -0.34 |
| Stochastic Oscillator | 32.68 | 9.80 |
Price Performance
Historical ComparisonAbout BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About SA Seabridge Gold Inc. (Canada)
Seabridge Gold Inc is a development stage company involved in the exploration and development of gold properties situated in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, the Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.